lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
---|---|---|---|---|---|---|---|---|---|---|---|
SNAI3-AS1 | Zika virus (MR766 strain of ZIKV (African lineage)) | MOI < 0.1 ;
56 hr |
Human neural progenitor cells (hPCs) | RNA-Seq | 0.442100884 | Downregulation | p ≤ 0.05 | Cuffdiff | two Sample t-test | 2017 | 29116029 |
SNAI3-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 0.48226232 | Downregulation | 2.04E-05 | student's t test | 2020 | 32416070 | |
SNAI3-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 0.484685222 | Downregulation | 0.003363151 | student's t test | 2020 | 32416070 | |
SNAI3-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 0.526753536 | Downregulation | 0 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose